or Try an Advanced Search...

    Diffuse Large B Cell Lymphoma Stocks List

    Symbol Grade Name % Change
    VIRX D Viracta Therapeutics, Inc. -5.75
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Anatomical Pathology Antiviral Drug Cancer Hematology Lymphoma

    Related ETFs - A few ETFs which own one or more of the above listed Diffuse Large B Cell Lymphoma stocks.

    Symbol Grade Name Weight
    IWC C iShares Microcap ETF 0.01
    VXF C Vanguard Extended Market ETF 0.0
    View all Diffuse Large B Cell Lymphoma ETFs...
    Compare ETFs
    Compare IWC to VXF

        Diffuse Large B Cell Lymphoma Stocks Recent News

        Date Stock Title
        Apr 15 VIRX Viracta slides on lower response rate in trial for lymphoma treatment cohort
        Apr 15 VIRX Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma
        Related Industries: Biotechnology
        Related Stock Lists: Anatomical Pathology Antiviral Drug Cancer Hematology Lymphoma
        Diffuse Large B Cell Lymphoma

        Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma, a cancer of the lymphatic system. It is the most common type of non-Hodgkin lymphoma in adults. DLBCL is an aggressive form of cancer that can spread quickly to other parts of the body. It is usually treated with chemotherapy and/or radiation therapy.

        Browse All Tags